BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 8, 1999
View Archived Issues
Aviron: Q4 1998 highlights
Read More
NeoRx: Q4 1998 highlights
Read More
Viragen: Q2 1998 highlights
Read More
Agouron solves structure of key target for drugs to block angiogenesis
Read More
Hemosol successfully completes phase II trial of Hemolink in CABG patients
Read More
Uncompetitive NMDA antagonists show improved efficacy in Parkinson's disease models
Read More
Novel AD and metabolic syndrome targets as focus of Exelixis and P&U collaboration
Read More
Spotlight on agents for peripheral vascular disease
Read More
New anticancer agents from LG Chemical inhibit farnesyltransferase
Read More
Antithrombotic P2T antagonists in development at Astra
Read More
Muscarinic receptor modulators for psychotic disorders patented by Lilly
Read More
Bupropion more effective than nicotine patches in smoking cessation therapy
Read More
Merck discloses novel endothelin receptor antagonists
Read More
Chemokine receptor modulators from Merck & Co. described in recent patent literature
Read More
Cyclooxygenase-inhibitory indoles under study at Pfizer
Read More
Texas Biotechnology: Q4 and year-end 1998 results
Read More
Na+/Ca2+ exchange inhibitor provides effective neuroprotection in vitro
Read More
Findings from burn study demonstrate advantage of Apligraf + autograft versus autograft alone
Read More
Study suggests potential of MS-325 in blood pool imaging
Read More
diaDexus's first diagnostic product licensed to SmithKline Beecham unit
Read More
Pharmacia & Upjohn and Centocor to copromote Fragmin in unstable angina
Read More
Bio-Technology General receives added patent protection for novel anticoagulant
Read More
FDA approves controlled-release form of popular antidepressant
Read More
North American Vaccine adds new product to R&D pipeline; U.S. patent issues
Read More
Xenova reveals structure of P-gp-mediated MDR modulators, including clinical compound XR-9576
Read More
Microbial metabolite inhibits ICAM-1/LFA-1-mediated cell adhesion
Read More
Microbial fatty acid enhances endothelial cell fibrinolytic activity
Read More